Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Aug;19(8):1175-82.
doi: 10.1007/s00520-010-0934-6. Epub 2010 Jun 24.

The development and validation of a quality-of-life questionnaire for head and neck cancer patients with enteral feeding tubes: the QOL-EF

Affiliations

The development and validation of a quality-of-life questionnaire for head and neck cancer patients with enteral feeding tubes: the QOL-EF

Christiaan Seimeon Michael Stevens et al. Support Care Cancer. 2011 Aug.

Abstract

Purpose: To develop a questionnaire that measures the impact of enteral feeding tubes (EFTs) on the quality of life (QOL) of head and neck cancer (HNC) patients

Methods: The development of the questionnaire (QOL-EF) was done in four phases. Phase 1-3 included: (1) literature review and consultation with an expert focus group (item generation), (2) pilot-testing in 12 patients and, (3) judgmental item reduction. In phase 4, the QOL-EF, FACT-H&N, and UW-QOL were administered to a cross-sectional group of HNC patients on active EFT feeding to test the reliability and validity of the QOL-EF.

Results: A 20-item QOL-EF was developed. In phase 4, 72 patients were accrued over 2.5 years, 31 of which were part of the test-retest subgroup. Cronbach's α for the QOL-EF was 0.73, and test-retest reliability was 0.83. Moderate correlations were observed between scores for the QOL-EF and both the FACT-H&N (-0.58) and the UW-QOL (-0.42).

Conclusions: The QOL-EF is a treatment-specific QOL instrument developed and validated for use in HNC patients with EFTs. It may become an important tool in evaluating treatment outcomes and complications in these patients.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Nutrition. 2003 Jul-Aug;19(7-8):605-11 - PubMed
    1. Cancer. 2001 May 1;91(9):1785-90 - PubMed
    1. Br J Cancer. 2000 Jan;82(2):263-9 - PubMed
    1. Arch Fam Med. 1993 Sep;2(9):953-6 - PubMed
    1. J Clin Nurs. 2003 Jul;12(4):562-70 - PubMed

Publication types

LinkOut - more resources